摘要
目的:观察黑素瘤抑制蛋白(MIA/CD-RAP)启动子在小鼠体内的表达活性。方法:利用PCR技术扩增2.2 kb 的MIA/CD-RAP启动子,分子克隆技术构建MIA 启动子-半乳糖苷酶(2.2lacZ)载体,显微注射法将纯化的2.2lacZDNA 注入来自B6SJL杂交小鼠受精卵的原核以制备转基因小鼠。提取幼鼠尾DNA,用lacZ特异性引物筛选阳性转基因小鼠。结果:8只首建小鼠染色体基因组整合有2.2lacZ融合基因。X-gal全胚胎染色发现其中3 只转基因小鼠在软骨和乳腺组织中均可见转基因的表达。结论:2.2 kb
Objective: To investigate the expression pattern of 2.2 kb melanoma inhibitory protein (MIA) promoter in vivo . Methods: 2.2 kb of MIA promoter was amplified by PCR and cloned into lacZ expression vector placF by recombinant techniques to generate MIA promoter lacZ construct (2.2lacZ). Purified DNA was microinjected into the pronuclei of fertilized eggs from B6SJL hybrid to produce transgenic mice. Founder mice were identified by PCR assays of the genomic DNA extracted from tails. Results: Eight transgenic founder mice carrying 2.2lacZ fusion gene were obtained. Whole mount staining with X gal demonstrated 2.2lacZ generated expression in cartilage and mammary glands in 3 transgenic mice. Conclusion: The 2.2 kb of the MIA promoter contains cis acting elements which can generate tissue specific expression in vivo .
出处
《第二军医大学学报》
CAS
CSCD
北大核心
2000年第1期27-28,I001,共3页
Academic Journal of Second Military Medical University
基金
国家"863"计划资助!项目(102-10-04-03
关键词
黑素瘤抑制蛋白
小鼠
转基因
基因调控
melanoma inhibitory protein
cartilage derived retinoic acid sensitive protein
mice,transgenic
gene regulation